Hepatitis C - Houston TX (Clinical Trial # 14683)
| City: |
|
Houston |
| State: |
|
TX |
| Zip Code: |
|
77079 |
| Study summary: |
|
A phase 3, safety and efficacy study of boceprevir/Peginterferon Alfa-2a/ribavirin in Chronic HCV Genotype 1 IL28B CC subjects. |
| Qualified participants must: |
|
• Be 18 years of age or older
•
Have previous documented Chronic Hepatitis C genotype 1 infection
|
| Participants may receive: |
|
Study related care, diagnostic test, and study medication at no cost. Payment for time and travel to the study center may be provided. |
| Study is available at: |
|
Houston Endoscopy and Research Center
Dr. Vikram Jayanty
10837 Katy Freeway
Suite 175
Houston, TX 77079
View Clinic Location
If you meet the above criteria and live within 50 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.
or
Click "View Contact Phone Number" to get the clinic's phone number.
|
| Phone number: |
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.